Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-03

Clinical Trial Update: Radiosurgery Plus Bevacizumab in Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports the termination of an early Phase 1 study evaluating radiosurgery in combination with bevacizumab for glioblastoma and gliosa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Glioblastoma, Gliosarcoma | EARLY_Phase 1 | Status: TERMINATED